- Switzerland will need to discard around 9 million doses of Moderna Inc's MRNA COVID-19 vaccine that have reached their expiry date.
- The wastage reflects the Swiss strategy of ordering more vaccines than needed to ensure its population of around 8.7 million would get sufficient supplies despite supply bottlenecks or quality issues.
- Related: Moderna's Omicron-Adapted Booster Maintains Response Through Three Months.
- "With this deliberately chosen strategy, it was accepted that too much vaccine would be procured and that some of the procured doses would have to be sold, passed on, or possibly destroyed," the cabinet said.
- Since the end of 2020, Reuters reported Switzerland received 31.9 million vaccine doses from Moderna and other suppliers, of which 16.1 million have been administered. Another 3.2 million were passed on to third countries, the government said.
- Last month, the Swiss health ministry announced to discard 10.3 million doses of Moderna's COVID-19 vaccine.
- The ministry said it had no choice but to eliminate the shots after the doses expired.
- Price Action: MRNA shares are up 0.39% at $124 during the premarket session on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in